Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Gastric Cancer

  Free Subscription

Articles published in Clin Cancer Res

Retrieve available abstracts of 38 articles:
HTML format

Single Articles

    April 2021
  1. WIEDERMANN U, Garner-Spitzer E, Chao Y, Maglakelidze M, et al
    Clinical and immunologic responses to a B-cell epitope vaccine in HER2/neu overexpressing advanced gastric cancer patients - results from Phase 1b trial IMU.ACS.001.
    Clin Cancer Res. 2021 Apr 20. pii: 1078-0432.CCR-20-3742.
    PubMed     Abstract available

    March 2021
  2. LEI M, Siemers NO, Pandya D, Chang H, et al
    Analyses of PD-L1 and Inflammatory Gene Expression Association with Efficacy of Nivolumab{plus minus}Ipilimumab in Gastric Cancer/Gastroesophageal Junction Cancer.
    Clin Cancer Res. 2021 Mar 29. pii: 1078-0432.CCR-20-2790.
    PubMed     Abstract available

    February 2021
  3. LEE IS, Lee H, Hur H, Kanda M, et al
    Transcriptomic Profiling Identifies A Risk Stratification Signature for Predicting Peritoneal Recurrence and Micrometastasis in Gastric Cancer.
    Clin Cancer Res. 2021 Feb 8. pii: 1078-0432.CCR-20-3835.
    PubMed     Abstract available

    December 2020
  4. NAKAJIMA TE, Kadowaki S, Minashi K, Nishina T, et al
    Multicenter phase I/II study of nivolumab combined with paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer.
    Clin Cancer Res. 2020 Dec 1. pii: 1078-0432.CCR-20-3559.
    PubMed     Abstract available

    November 2020
  5. PARK J, Jang BG, Kim YW, Park H, et al
    A prospective validation and observer performance study of a deep learning algorithm for pathologic diagnosis of gastric tumors in endoscopic biopsies.
    Clin Cancer Res. 2020 Nov 10. pii: 1078-0432.CCR-20-3159.
    PubMed     Abstract available

    April 2020
  6. GALLETTI G, Zhang C, Gjyrezi A, Cleveland K, et al
    Microtubule engagement with taxane is altered in taxane-resistant gastric cancer.
    Clin Cancer Res. 2020 Apr 22. pii: 1078-0432.CCR-19-3018.
    PubMed     Abstract available

  7. KANG YK, Bang YJ, Kondo S, Chung HC, et al
    Safety and Tolerability of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-beta and PD-L1, in Asian Patients with Pretreated Recurrent or Refractory Gastric Cancer.
    Clin Cancer Res. 2020 Apr 16. pii: 1078-0432.CCR-19-3806.
    PubMed     Abstract available

    March 2020
  8. KUBOTA Y, Kawazoe A, Sasaki A, Mishima S, et al
    The impact of molecular subtype on efficacy of chemotherapy and checkpoint inhibition in advanced gastric cancer.
    Clin Cancer Res. 2020 Mar 10. pii: 1078-0432.CCR-20-0075.
    PubMed     Abstract available

    February 2020
  9. KELLY RJ, Lee J, Bang YJ, Almhanna K, et al
    Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma.
    Clin Cancer Res. 2020;26:846-854.
    PubMed     Abstract available

  10. SATHE A, Grimes SM, Lau BT, Chen J, et al
    Single cell genomic characterization reveals the cellular reprogramming of the gastric tumor microenvironment.
    Clin Cancer Res. 2020 Feb 14. pii: 1078-0432.CCR-19-3231.
    PubMed     Abstract available

    July 2019
  11. GREALLY M, Chou JF, Chatila WK, Margolis M, et al
    Clinical and molecular predictors of response to immune checkpoint inhibitors in patients with advanced esophagogastric cancer.
    Clin Cancer Res. 2019 Jul 23. pii: 1078-0432.CCR-18-3603.
    PubMed     Abstract available

    April 2019
  12. VAN CUTSEM E, Karaszewska B, Kang YK, Chung HC, et al
    A Multicenter Phase II Study of AMG 337 in Patients with MET-Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma and Other MET-Amplified Solid Tumors.
    Clin Cancer Res. 2019;25:2414-2423.
    PubMed     Abstract available

  13. WON E, Basunia A, Chatila WK, Hechtman JF, et al
    Efficacy of combined VEGFR1-3, PDGFalpha/beta, and FGFR1-3 blockade using nintedanib for esophagogastric cancer.
    Clin Cancer Res. 2019 Apr 5. pii: 1078-0432.CCR-18-3789.
    PubMed     Abstract available

    February 2019
  14. JEONG MH, Park SY, Lee SH, Seo J, et al
    EPB41L5 mediates TGF--induced metastasis of gastric cancer.
    Clin Cancer Res. 2019 Feb 27. pii: 1078-0432.CCR-18-2959.
    PubMed     Abstract available

  15. ZHOU Z, Xia GK, Xiang Z, Liu M, et al
    A C-X-C chemokine receptor type 2-dominated crosstalk between tumor cells and macrophages drives gastric cancer metastasis.
    Clin Cancer Res. 2019 Feb 22. pii: 1078-0432.CCR-18-3567.
    PubMed     Abstract available

  16. WANG X, Liang JQ, Zhang LH, Gou H, et al
    C8orf76 promotes gastric tumorigenicity and metastasis by directly inducing lncRNA DUSP5P1 and associates with patient outcomes.
    Clin Cancer Res. 2019 Feb 7. pii: 1078-0432.CCR-18-2804.
    PubMed     Abstract available

    January 2019
  17. BALTSCHUKAT S, Schacher Engstler B, Huang A, Hao HX, et al
    Capmatinib (INC280) Is Active Against Models of Non-Small Cell Lung Cancer and Other Cancer Types with Defined Mechanisms of MET Activation.
    Clin Cancer Res. 2019 Jan 23. pii: 1078-0432.CCR-18-2814.
    PubMed     Abstract available

  18. XU J, Zhang Y, Jia R, Yue C, et al
    Anti-PD-1 Antibody SHR-1210 Combined with Apatinib for Advanced Hepatocellular Carcinoma, Gastric, or Esophagogastric Junction Cancer: An Open-label, Dose Escalation and Expansion Study.
    Clin Cancer Res. 2019;25:515-523.
    PubMed     Abstract available

    December 2018
  19. QIAO G, Wang XL, Zhou L, Zhou XN, et al
    Autologous dendritic cell-cytokine induced killer cell immunotherapy combined with S-1 plus cisplatin in patients with advanced gastric cancer: A prospective study.
    Clin Cancer Res. 2018 Dec 4. pii: 1078-0432.CCR-18-2360.
    PubMed     Abstract available

    November 2018
  20. GAMBARDELLA V, Gimeno-Valiente F, Tarazona N, Martinez Ciarpaglini C, et al
    NRF2 through RPS6 activation is related to anti-HER2 drug resistance in HER2-amplified gastric cancer.
    Clin Cancer Res. 2018 Nov 30. pii: 1078-0432.CCR-18-2421.
    PubMed     Abstract available

  21. MERIC-BERNSTAM F, Johnson A, Ileana Dumbrava EE, Raghav K, et al
    Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer.
    Clin Cancer Res. 2018 Nov 15. pii: 1078-0432.CCR-18-2275.
    PubMed     Abstract available

    October 2018
  22. LIN S, Wang X, Pan Y, Tian R, et al
    Transcription Factor Myeloid Zinc-Finger 1 Suppresses Human Gastric Carcinogenesis by Interacting with Metallothionein 2A.
    Clin Cancer Res. 2018 Oct 9. pii: 1078-0432.CCR-18-1281.
    PubMed     Abstract available

    July 2018
  23. YONG WP, Rha SY, Tan IB, Choo SP, et al
    Real-time Tumor Gene Expression Profiling to Direct Gastric Cancer Chemotherapy: Proof-of-Concept '3G' Trial.
    Clin Cancer Res. 2018 Jul 25. pii: 1078-0432.CCR-18-0193.
    PubMed     Abstract available

  24. JIANG Y, Xie J, Han Z, Liu W, et al
    Immunomarker Support Vector Machine Classifier for Prediction of Gastric Cancer Survival and Adjuvant Chemotherapeutic Benefit.
    Clin Cancer Res. 2018 Jul 24. pii: 1078-0432.CCR-18-0848.
    PubMed     Abstract available

  25. LI Y, Zhang X, Liu D, Gong JF, et al
    Evolutionary expression of HER2 conferred by chromosome aneuploidy on circulating gastric cancer cells contributes to developing targeted and chemotherapeutic resistance.
    Clin Cancer Res. 2018 Jul 16. pii: 1078-0432.CCR-18-1205.
    PubMed     Abstract available

    May 2018
  26. ANDERSON BW, Suh YS, Choi B, Lee HJ, et al
    Detection of Gastric Cancer with Novel Methylated DNA Markers: Discovery, Tissue Validation, and Pilot Testing in Plasma.
    Clin Cancer Res. 2018 May 29. pii: 1078-0432.CCR-17-3364.
    PubMed     Abstract available

    January 2018
  27. CHEN X, Chen Z, Yu S, Nie F, et al
    Long noncoding RNA LINC01234 functions as a competing endogenous RNA to regulate CBFB expression by sponging miR-204-5p in gastric cancer.
    Clin Cancer Res. 2018 Jan 31. pii: 1078-0432.CCR-17-2376.
    PubMed     Abstract available

  28. XIE K, Kong F, Sun T, Kong X, et al
    Kruppel-like Factor 4 Suppresses Serine/Threonine Kinase 33 Activation and Metastasis of Gastric Cancer through Reversing Epithelial-Mesenchymal Transition.
    Clin Cancer Res. 2018 Jan 24. pii: 1078-0432.CCR-17-3346.
    PubMed     Abstract available

  29. YU L, Wu D, Gao H, Balic J, et al
    Clinical utility of a STAT3-regulated microRNA-200 family signature with prognostic potential in early gastric cancer.
    Clin Cancer Res. 2018 Jan 12. pii: 1078-0432.CCR-17-2485.
    PubMed     Abstract available

    December 2017
  30. PIETRANTONIO F, Fuca G, Morano F, Gloghini A, et al
    Biomarkers of primary resistance to trastuzumab in HER2-positive metastatic gastric cancer patients: the AMNESIA case-control study.
    Clin Cancer Res. 2017 Dec 5. pii: 1078-0432.CCR-17-2781.
    PubMed     Abstract available

    July 2017
  31. SOHN BH, Hwang JE, Jang HJ, Lee HS, et al
    Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project.
    Clin Cancer Res. 2017 Jul 26. doi: 10.1158/1078-0432.CCR-16-2211.
    PubMed     Abstract available

    January 2017
  32. DONG J, Wang R, Ren G, Li X, et al
    HMGA2-FOXL2 Axis Regulates Metastases and Epithelial-to-mesenchymal Transition of Chemo-resistant Gastric Cancer.
    Clin Cancer Res. 2017 Jan 24. pii: clincanres.2180.2016.
    PubMed     Abstract available

    October 2016
  33. DU X, Xu MD, Wang Y, Weng WW, et al
    A positive feedback loop of lncRNA-PVT1 and FOXM1 facilitates gastric cancer growth and invasion.
    Clin Cancer Res. 2016 Oct 18. pii: clincanres.0742.2016.
    PubMed     Abstract available

  34. MERCOGLIANO MF, De Martino M, Venturutti L, Rivas MA, et al
    TNFalpha-induced Mucin 4 Expression Elicits Trastuzumab Resistance in HER2-Positive Breast Cancer.
    Clin Cancer Res. 2016 Oct 3. pii: clincanres.0970.2016.
    PubMed     Abstract available

    September 2016
  35. LEE KW, Lee SS, Hwang JE, Jang HJ, et al
    Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer.
    Clin Cancer Res. 2016 Sep 21. pii: clincanres.2468.2015.
    PubMed     Abstract available

  36. NGUYEN PH, Giraud J, Chambonnier L, Dubus P, et al
    Characterization of biomarkers of tumorigenic and chemoresistant cancer stem cells in human gastric carcinoma.
    Clin Cancer Res. 2016 Sep 12. pii: clincanres.2157.2015.
    PubMed     Abstract available

  37. LI TJ, Jiang Y, Hu YF, Huang L, et al
    Interleukin-17-producing neutrophils link inflammatory stimuli to disease progression by promoting angiogenesis in gastric cancer.
    Clin Cancer Res. 2016 Sep 12. pii: clincanres.0617.2016.
    PubMed     Abstract available

    February 2016
  38. YOON C, Cho SJ, Aksoy BA, Park do J, et al
    Chemotherapy Resistance in Diffuse-Type Gastric Adenocarcinoma Is Mediated by RhoA Activation in Cancer Stem-Like Cells.
    Clin Cancer Res. 2016;22:971-83.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.